Home > Healthcare > Medical Devices > Therapeutic Devices > U.S. Intrauterine Devices Market

U.S. Intrauterine Devices Market Share

Report ID: GMI2895
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

U.S. Intrauterine Devices Market Share

The U.S. intrauterine devices industry is consolidated in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel IUD devices with improved efficiency and cost-effectiveness are key market strategies for device manufacturers, driving competition and innovation in the industry.

U.S. Intrauterine Devices Market Companies

Some of the eminent market participants operating in the U.S. intrauterine devices industry include:

Allergan (AbbVie Inc.)
Bayer AG
CooperSurgical Inc.
Durbin
Meril Life Sciences Pvt. Ltd.
Mylan N.V. (Viatris)
Pregna International Ltd.
SMB Corporation of India

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. intrauterine devices industry size was worth USD 1.4 billion in 2023 and will grow at 9.5% CAGR between 2024 and 2032 due to increasing awareness and acceptance of long-term, reversible contraceptive methods.

U.S. intrauterine devices market from the hospital segment recorded 49% share in 2023, driven by the extensive resources and specialized care available in these facilities.

South Atlantic U.S. intrauterine devices industry captured USD 275.5 million in 2023, attributed to large population, growing healthcare access, and increasing awareness of reproductive health.

Prominent players operating in the U.S. intrauterine devices industry are Allergan (AbbVie Inc.), Bayer AG, CooperSurgical Inc., Durbin, Meril Life Sciences Pvt. Ltd., Mylan N.V. (Viatris), Pregna International Ltd., and SMB Corporation of India, among others.